Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × abemaciclib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 12 Neoplasm Metastasis 4 Prostatic Neoplasms 3 Glioma 3 Brain Neoplasms 3 Sarcoma, Ewing 2 Recurrence 2 Neoplasms 2 Meningioma 2 Glioblastoma 2 Endometrial Neoplasms 2 Unilateral Breast Neoplasms 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm, Residual 1 Multiple Myeloma 1 Medulloblastoma 1 Malignant Neoplasms of Female Genital Organs 1 Lymphoma, Non-Hodgkin 1 Liver Metastases From Colorectal Cancer (mCRC) 1 Liposarcoma 1 Leiomyosarcoma 1 Hemangiosarcoma 1

Interventions

Nivolumab 19 cabozantinib 14 Magnetic Resonance Spectroscopy 14 pembrolizumab 12 Specimen Handling 12 Ipilimumab 12 lenvatinib 5 Biopsy 5 atezolizumab 4 Immunoglobulin G 4 Everolimus 4 CTLA-4 Antigen 4 Axitinib 4 pazopanib 3 cemiplimab 3 Disulfides 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 tivozanib 2 spartalizumab 2 belzutifan 2 avelumab 2 aldesleukin 2 aflibercept 2 Watchful Waiting 2 Pluvicto 2 Nephrectomy 2 IFL protocol 2 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡